The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, can improve care transitions for adults being discharged from the hospital. AKI is a sudden decrease in kidney function that can occur during a hospital stay.
The main questions this study aims to answer are:
* Does an AKI discharge summary template improve communication about AKI after hospital discharge? * Does a chat-based educational messaging program improve patient understanding of AKI and support follow-up care after hospital discharge? * Researchers will compare usual care, an AKI discharge summary template, a chat-based educational messaging program, and the combination of the discharge summary template plus chat-based messaging.
Researchers will compare four groups:
* Usual care * An AKI discharge summary template * A chat-based educational messaging program * Both the AKI discharge summary template and the chat-based educational messaging program
Participants will complete questionnaires at the start of the study and about 4 weeks after hospital discharge. Participants will also receive a brief phone call about 3 months after discharge, and the research team will review their medical record for information about follow-up care, lab testing, emergency department visits, and hospital readmissions.
Age 18 years or older
Hospitalized with Stage 2 or Stage 3 acute kidney injury
Kidney function has not returned to baseline at the time of hospital discharge
Able to communicate in English
Acute kidney injury requiring ongoing dialysis at the time of hospital discharge
End-stage kidney disease
Kidney transplant recipient
Currently pregnant
Parallel
AKI Discharge Summary Template
BehavioralThe AKI discharge summary template provides structured AKI-related information for the hospital discharge summary, including information about the AKI episode and recommended follow-up care. The template is intended to improve communication during the transition from hospital to outpatient care.
Chat-Based Educational Messaging Program
BehavioralThe chat-based educational messaging program provides AKI-related educational messages after hospital discharge. Messages are delivered through a secure web-based chat-style interface and are designed to support patient understanding of AKI, post-discharge follow-up, and kidney-related care after hospitalization.
Feasibility: Eligible patient enrollment
Percentage of eligible patients enrolled among those approached.
Feasibility: Participant retention
Percentage of enrolled participants who complete the follow-up assessment.
Feasibility: Successful delivery of assigned intervention components
Percentage of participants assigned to an intervention arm who receive the assigned intervention component or components as intended, including the AKI discharge summary template and/or chat-based educational messaging program.
AKI Knowledge Score
Participant AKI knowledge score measured using a study questionnaire.
Patient experience during care transitions
Patient-reported care transition experience measured using a validated transition-of-care instrument, such as the Care Transitions Measure-15.
Self-management behaviors related to kidney health
Participant-reported self-management behaviors related to kidney health after hospital discharge, assessed using a study questionnaire.
Adherence to outpatient follow-up appointments
Percentage of participants who complete follow-up with a primary care provider or specialist after hospital discharge, assessed by participant report and/or medical record review.
Hospital readmission
Percentage of participants readmitted to the hospital after discharge from the index hospitalization.
Kidney function trajectory after discharge
Kidney function status after hospital discharge, categorized as improved, stable, worsened, or requiring dialysis, based on available laboratory and clinical data.
Click on the lead sponsor to view all of their trials.
Northwell Health
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
